BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 28.35
0.00 (0.00%)
Oct 30, 2026, 9:49 AM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 726.1 million as of October 30, 2026. It is the 36,058th most valuable company in the world and the 2,168th biggest in Taiwan. Its market cap has decreased by 10.43% in one year.
Market Cap
726.10M
Enterprise Value
671.84M
Revenue
258.04M
Global Rank
Country Rank
#2,168 Taiwan
PE Ratio
17.83
ChartMarket Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 726.10M, a decrease of -54.07%. That is a compound annual growth rate of -8.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 726.10M | -8.55% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCI GENE | 964.41M |
| Holy Stone Healthcare | 950.29M |
| GeneReach Biotechnology | 949.53M |
| MegaPro Biomedical | 915.80M |
| Meribank Biotech | 865.70M |
| NatureWise Biotech & Medicals | 765.61M |
| Lukas Biomedical | 736.99M |
| Neith | 720.61M |